cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases
Ageing Research Reviews · 2025-03 · 105 · 102691
DOI: 10.1016/j.arr.2025.102691 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025-03. Verfasst von Hongquan Wang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100049, China. Hauptthemen laut MEDLINE: Nucleotidyltransferases, Membrane Proteins, Nervous System Diseases. Die Arbeit wurde bisher 55-mal zitiert (Crossref) und nennt 196 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Cyclic guanosine monophosphate (GMP)-adenosine monophosphate (AMP) (cGAMP) synthase (cGAS) is a cytosolic DNA sensor that produces the secondary messenger cGAMP. cGAMP activates the endoplasmic reticulum-associated adaptor stimulator of interferon genes (STING) and activates the innate immune system to produce a type I interferon response. Besides sensing microbial DNA, cGAS can also be activated by self-DNA or endogenous DNA, including that derived from genotoxic extranuclear chromatin and mitochondrially released DNA, indicating that cGAS-STING is an important mechanism in sterile inflammatory responses, autoimmunity, and cellular senescence. However, aberrant activation of the cGAS-STING pathway results in inflammatory and autoimmune diseases. cGAS-STING has emerged as a vital mechanism driving the pathogenesis of inflammation, implicating cGAS-STING signaling in neurological diseases. In this review, we first outline the principal elements of the cGAS-STING signaling cascade, summarizing recent research highlighting how cGAS-STING activation contributes to the pathogenesis of neurological diseases, including various autoimmune, autoinflammatory, and neurodegenerative diseases. Next, we outline selective small-molecule modulators that function as cGAS-STING inhibitors and summarize their mechanisms for treating multiple neurological diseases. Finally, we discuss key limitations of the current therapeutic paradigm and generate possible strategies to overcome them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100049, China.
- Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences, St. John's University, Queens, NY 11439, USA.
- Department of Neurology, Zhongnan Hospital of Wuhan University, Wuhan 430000, China.
- Aerospace Medical Center, Aerospace Center Hospital, Beijing 100049, China.
- Division of Neurobiology, Johns Hopkins University, Baltimore, MD 21205, USA. Electronic address: ldu13@jh.edu.
- Aerospace Medical Center, Aerospace Center Hospital, Beijing 100049, China. Electronic address: 13701189314@163.com.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, H., Fleishman, J. S., Wu, S., Wang, G., Du, L., Li, J., & Du, J. (2025). cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases. Ageing Research Reviews, 105, 102691. https://doi.org/10.1016/j.arr.2025.102691
Vancouver
Wang H, Fleishman JS, Wu S, Wang G, Du L, Li J, et al. cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases. Ageing Research Reviews. 2025;105:102691. doi:10.1016/j.arr.2025.102691
BibTeX
@article{Wang2025,
author = {Wang, Hongquan and Fleishman, Joshua S and Wu, Shuang and Wang, Guan and Du, Lida and Li, Jilai and Du, Jichen},
title = {cGAS-STING targeting offers novel therapeutic opportunities in neurological diseases},
journal = {Ageing Research Reviews},
year = {2025},
volume = {105},
pages = {102691},
doi = {10.1016/j.arr.2025.102691}
}
EUVIMED